Síndrome de Miller-Fisher seguido por vacuna Sputnik V
Miller-Fisher syndrome (MFS), defined as a rare variant of Guillain-Barré syndrome (GBS), is characterized by the classic triad of ataxia, areflexia, and ophthal-moplegia. It is a demyelinating polyneuropathy resulting from a deregulated autoimmune response secondary to infection by viruses and bact...
I tiakina i:
| Kaituhi matua: | |
|---|---|
| Hōputu: | Pukapuka |
| I whakaputaina: |
Asociación Colombiana de Infectología,
2022-08-01T00:00:00Z.
|
| Ngā marau: | |
| Urunga tuihono: | Connect to this object online. |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
| Whakarāpopototanga: | Miller-Fisher syndrome (MFS), defined as a rare variant of Guillain-Barré syndrome (GBS), is characterized by the classic triad of ataxia, areflexia, and ophthal-moplegia. It is a demyelinating polyneuropathy resulting from a deregulated autoimmune response secondary to infection by viruses and bacteria. SMF and GBS have been described during the COVID-19 pandemic. There are some reports in the literature of GBS after vaccination for COVID-19. In contrast, reports of post-vaccination FMS for SARS-CoV-2 are scarce in the literature. A 75-year-old patient is presented who consults for asthenia, adynamia, and difficulty swallowing that progresses to respiratory distress. She refers to the application of the Sputnik V vaccine as an important antecedent. During the hospital stay, the diagnosis was made by electromyography and nerve conduction study of GBS variant SMF. The objective is to expose a post-vaccination SMF to SARS-CoV-2 with the biological Sputnik V and highlight the importance of this background for surveillance in clinical practice and future research. |
|---|---|
| Whakaahutanga tūemi: | https://doi.org/10.22354/24223794.1097 0123-9392 |